FLASCO Fall Session - Florida Society of Clinical Oncology Fall Session

Group of pharmacists -- Image credit: .shock | stock.adobe.com

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

ByNicole Bentivegna, PharmD, BCOP,Gabriela Aponte-Melendez, PharmD,Natalie Kaufman, PharmD,Cooper Bailey, PharmD

December 27th 2024

The program develops patient-centered oncology pharmacists through comprehensive training.

FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer

ByAlana Hippensteele, Lead Editor

November 3rd 2024

Two clinical trials with MRD monitoring may be practice changing: TRACERx and AEGEAN.

Pharmacist Involvement Within ASCO: Standards Development, Certification Programs, and the Potential for Pharmacy CE at Future ASCO Meetings

ByAlana Hippensteele, Lead Editor

November 2nd 2024

ASCO is prioritizing the expansion of pharmacist involvement in its organization by recognizing pharmacists' contributions to safety standards, quality improvement initiatives, and certification programs.

FLASCO Fall Session - Florida Society of Clinical Oncology Fall Session

Shaping the Future of Oncology Pharmacy Through the NCODA Medically Integrated Oncology Pharmacy Residency Program

FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer

Pharmacist Involvement Within ASCO: Standards Development, Certification Programs, and the Potential for Pharmacy CE at Future ASCO Meetings

Trending on Pharmacy Times

Tirzepatide Cuts MACE Risk in Diabetes With Heart Disease

CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal

The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline

FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine

Real-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss